What is Pulse Biosciences, Inc.'s accounts receivable?

Pulse Biosciences, Inc. (PLSE) reported accounts receivable of $157K in Q1 2026.

What is the long-term trend for Pulse Biosciences, Inc.'s accounts receivable?

Over 2 years (2021 to 2023), Pulse Biosciences, Inc.'s accounts receivable has grown at a -100.0% compound annual growth rate (CAGR), from $163.5K to $0.

What does accounts receivable mean?

Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.

Pulse Biosciences, Inc. PLSE Accounts Receivable

Accounts Receivable at other companies

AbbottABT

$8.21B+12.1%

Johnson & JohnsonJNJ

$17.72B+10.6%

Boston ScientificBSX

$3.15B+12.4%

AtriCureATRC

$71.31M+12.6%

MedtronicMDT

$6.64B+2.0%

Merit Medical SystemsMMSI

$206.45M+3.5%

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.77B+38.4%

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsReceivableNetCurrent.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s accounts receivable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s accounts receivable?: Pulse Biosciences, Inc. (PLSE) reported accounts receivable of $157K in Q1 2026.
What is the long-term trend for Pulse Biosciences, Inc.'s accounts receivable?: Over 2 years (2021 to 2023), Pulse Biosciences, Inc.'s accounts receivable has grown at a -100.0% compound annual growth rate (CAGR), from $163.5K to $0.
What does accounts receivable mean?: Amounts owed by customers for goods delivered or services performed, net of allowances for doubtful accounts. A key working capital component.